NLRP3 and early-onset autosomal dominant Alzheimer disease: The article ranked third in terms of citations was “Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models” by (Daniels et al., 2016), with 263 citations.